STC-004

N/A

Report date: 2025/05/28 11:09:04
NME

Base Information

Drug NameSTC-004
Drug Alias NameSTC-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit inhibitors
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsChronic PainAcute PainPain +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew Zealand
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanySiteone Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsChronic PainAcute PainPain +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A